Growth Metrics

Merck (MRK) EPS (Basic) Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -29.15%
Dec 31, 2025 28.16%
Sep 30, 2025 14.87%
Jun 30, 2025 13.61%
Mar 31, 2025 9.62%
Dec 31, 2024 9.74%
Sep 30, 2024 11.05%
Jun 30, 2024 15.63%
Mar 31, 2024 10.72%
Dec 31, 2023 -21.98%
Sep 30, 2023 20.70%
Jun 30, 2023 -41.50%
Mar 31, 2023 32.68%
Dec 31, 2022 38.55%
Sep 30, 2022 131.16%
Jun 30, 2022 17.05%
Mar 31, 2022 24.87%
Dec 31, 2021 50.66%
Sep 30, 2021 18.03%
Jun 30, 2021 6.75%
Mar 31, 2021 21.37%
Dec 31, 2020 -34.32%
Sep 30, 2020 12.28%
Jun 30, 2020 31.12%
Mar 31, 2020 30.16%
Dec 31, 2019 -18.20%
Sep 30, 2019 19.01%
Jun 30, 2019 8.55%
Mar 31, 2019 14.27%
Dec 31, 2018 20.99%
Sep 30, 2018 13.95%
Jun 30, 2018 16.36%
Mar 31, 2018 -12.62%
Dec 31, 2017 -26.71%
Sep 30, 2017 -15.27%
Jun 30, 2017 3.77%
Mar 31, 2017 -0.35%
Dec 31, 2016 -19.33%
Sep 30, 2016 7.51%
Jun 30, 2016 -7.51%
Mar 31, 2016 3.82%
Dec 31, 2015 32.34%
Sep 30, 2015 42.66%
Jun 30, 2015 0.00%
Mar 31, 2015 27.73%
Dec 31, 2014 -0.77%
Sep 30, 2014 -28.16%
Jun 30, 2014 -1.39%
Mar 31, 2014 -2.84%